Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2018 Filed Apr 4, 2018 20:10 UTC |
Mento Steven JDirector
|
SaleCommon Stock | 100 | $18.90 | $1,890.00 |
DisclosureSEC source: 0001209191-18-023598 · doc4.xml · nonDerivative · entry 3 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,832 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2017. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:10 UTC |
Mento Steven JDirector
|
SaleCommon Stock | 7,115 | $18.39 | $130,868.33 |
DisclosureSEC source: 0001209191-18-023598 · doc4.xml · nonDerivative · entry 2 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,932 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2017. F2 · price: The price reported is a weighted average price. The shares were sold at prices ranging from $17.85 to $18.85 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:10 UTC |
Mento Steven JDirector
|
Exercise / conversionCommon Stock | 10,000 | $7.77 | $77,700.00 |
DisclosureSEC source: 0001209191-18-023598 · doc4.xml · nonDerivative · entry 1 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:09 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,563 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-18-023597 · doc4.xml · derivative · entry 5 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,125 Underlying: Common Stock · 1,563 shares Expires 2027-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the January 26, 2017 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:09 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 715 | $0.00 Strike: $9.41 | $0.00 |
DisclosureSEC source: 0001209191-18-023597 · doc4.xml · derivative · entry 4 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,605 Underlying: Common Stock · 715 shares Expires 2025-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:09 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
SaleCommon Stock | 2,278 | $18.30 | $41,683.76 |
DisclosureSEC source: 0001209191-18-023597 · doc4.xml · nonDerivative · entry 3 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,625 F1 · kind: All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017. F2 · price: The price reported is a weighted average price. The shares were sold at prices ranging from $18.069 to $18.80 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes (a) 8,375 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date; and (b) 6,250 shares subject to restricted stock units granted on December 8, 2015 that will vest on December 8, 2018, subject to the Reporting Person's continued service with the Issuer through such date. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:09 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 1,563 | $3.50 | $5,470.50 |
DisclosureSEC source: 0001209191-18-023597 · doc4.xml · nonDerivative · entry 2 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:09 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 715 | $9.41 | $6,728.15 |
DisclosureSEC source: 0001209191-18-023597 · doc4.xml · nonDerivative · entry 1 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 23:41 UTC |
Yi KathySVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-18-020419 · doc4.xml · derivative · entry 3 Yi Kathy · CIK 0001697802 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,000 Underlying: Common Stock · 5,000 shares Expires 2027-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the February 27, 2017 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 23:41 UTC |
Yi KathySVP & Chief Financial Officer
|
SaleCommon Stock | 5,000 | $25.56 | $127,812.00 |
DisclosureSEC source: 0001209191-18-020419 · doc4.xml · nonDerivative · entry 2 Yi Kathy · CIK 0001697802 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017. F2 · price: The price reported is a weighted average price. The shares were sold at prices ranging from $25.40 to $25.80 The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 23:41 UTC |
Yi KathySVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | $4.55 | $22,750.00 |
DisclosureSEC source: 0001209191-18-020419 · doc4.xml · nonDerivative · entry 1 Yi Kathy · CIK 0001697802 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 01:43 UTC |
Conner Edward R.Sr. VP & Chief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001209191-18-017884 · doc4.xml · derivative · entry 3 Conner Edward R. · CIK 0001691265 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 5,000 shares Expires 2026-11-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 01:43 UTC |
Conner Edward R.Sr. VP & Chief Medical Officer
|
SaleCommon Stock | 5,000 | $24.78 | $123,877.50 |
DisclosureSEC source: 0001209191-18-017884 · doc4.xml · nonDerivative · entry 2 Conner Edward R. · CIK 0001691265 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,125 F2 · kind: All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017. F3 · price: The price reported is a weighted average price. The shares were sold at prices ranging from $24.20 to $25.20 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 01:43 UTC |
Conner Edward R.Sr. VP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $3.20 | $16,000.00 |
DisclosureSEC source: 0001209191-18-017884 · doc4.xml · nonDerivative · entry 1 Conner Edward R. · CIK 0001691265 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:50 UTC |
Mento Steven JDirector
|
Exercise / conversionStockOption (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $5.03 | $0.00 |
DisclosureSEC source: 0001209191-18-016894 · doc4.xml · derivative · entry 6 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:50 UTC |
Mento Steven JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001209191-18-016894 · doc4.xml · derivative · entry 5 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:50 UTC |
Mento Steven JDirector
|
SaleCommon Stock | 9,433 | $23.27 | $219,546.47 |
DisclosureSEC source: 0001209191-18-016894 · doc4.xml · nonDerivative · entry 3 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,047 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2017. F2 · price: The price reported is a weighted average price. The shares were sold at prices ranging from $22.55 to $24.05 The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:50 UTC |
Mento Steven JDirector
|
Exercise / conversionCommon Stock | 10,000 | $5.03 | $50,300.00 |
DisclosureSEC source: 0001209191-18-016894 · doc4.xml · nonDerivative · entry 2 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:50 UTC |
Mento Steven JDirector
|
Exercise / conversionCommon Stock | 5,000 | $6.41 | $32,050.00 |
DisclosureSEC source: 0001209191-18-016894 · doc4.xml · nonDerivative · entry 1 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:39 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,312 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-18-016866 · doc4.xml · derivative · entry 9 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,688 Underlying: Common Stock · 5,312 shares Expires 2027-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock option vested and became exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured from the January 26, 2017 grant date, and the balance of the shares will vest and become exercisable in 36 successive equal monthly installments upon his completion of each additional month of service thereafter. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:39 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,430 | $0.00 Strike: $9.41 | $0.00 |
DisclosureSEC source: 0001209191-18-016866 · doc4.xml · derivative · entry 8 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,320 Underlying: Common Stock · 1,430 shares Expires 2025-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:39 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,087 | $0.00 Strike: $14.07 | $0.00 |
DisclosureSEC source: 0001209191-18-016866 · doc4.xml · derivative · entry 7 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,913 Underlying: Common Stock · 8,087 shares Expires 2024-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 11, 2014 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:39 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 171 | $0.00 Strike: $12.12 | $0.00 |
DisclosureSEC source: 0001209191-18-016866 · doc4.xml · derivative · entry 6 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 171 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:39 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
SaleCommon Stock | 15,000 | $23.06 | $345,861.00 |
DisclosureSEC source: 0001209191-18-016866 · doc4.xml · nonDerivative · entry 5 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,625 F1 · kind: All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017. F2 · price: The price reported is a weighted average price. The shares were sold at prices ranging from $22.60 to $23.60 The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes (a) 8,375 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date; and (b) 6,250 shares subject to restricted stock units granted on December 8, 2015 that will vest on December 8, 2018, subject to the Reporting Person's continued service with the Issuer through such date. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:39 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 5,312 | $3.50 | $18,592.00 |
DisclosureSEC source: 0001209191-18-016866 · doc4.xml · nonDerivative · entry 4 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:39 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 8,087 | $14.07 | $113,784.09 |
DisclosureSEC source: 0001209191-18-016866 · doc4.xml · nonDerivative · entry 3 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:39 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 1,430 | $9.41 | $13,456.30 |
DisclosureSEC source: 0001209191-18-016866 · doc4.xml · nonDerivative · entry 2 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:39 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 171 | $12.12 | $2,072.52 |
DisclosureSEC source: 0001209191-18-016866 · doc4.xml · nonDerivative · entry 1 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:19 UTC |
Turner Heather DSVP and General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0001209191-18-015618 · doc4.xml · derivative · entry 1 Turner Heather D · CIK 0001403571 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2028-02-27 F1 · derivative.exercise_date: One-quarter (1/4) of the option shares vest and became exercisable upon completion of one (1) year of service by the Reporting Person measured from February 12, 2018, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 23:41 UTC |
Ramasastry SairaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,450 | $0.00 Strike: $5.03 | $0.00 |
DisclosureSEC source: 0001209191-18-014220 · doc4.xml · derivative · entry 3 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,450 shares Expires 2022-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option is fully vested and exercisable. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 23:41 UTC |
Ramasastry SairaDirector
|
SaleCommon Stock | 9,450 | $24.88 | $235,080.09 |
DisclosureSEC source: 0001209191-18-014220 · doc4.xml · nonDerivative · entry 2 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported is a weighted average price. The shares were sold at prices ranging from $24.85 to $24.905 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 23:41 UTC |
Ramasastry SairaDirector
|
Exercise / conversionCommon Stock | 9,450 | $5.03 | $47,533.50 |
DisclosureSEC source: 0001209191-18-014220 · doc4.xml · nonDerivative · entry 1 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:17 UTC |
Conner Edward R.Sr. VP & Chief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001209191-18-008165 · doc4.xml · derivative · entry 3 Conner Edward R. · CIK 0001691265 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 5,000 shares Expires 2026-11-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:17 UTC |
Conner Edward R.Sr. VP & Chief Medical Officer
|
SaleCommon Stock | 5,000 | $18.49 | $92,435.50 |
DisclosureSEC source: 0001209191-18-008165 · doc4.xml · nonDerivative · entry 2 Conner Edward R. · CIK 0001691265 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,125 F2 · kind: All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2017. F3 · price: The price reported is a weighted average price. The shares were sold at prices ranging from $18.05 to $18.80 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date. Read SEC document |
| February 06, 2018 Filed Feb 7, 2018 22:17 UTC |
Conner Edward R.Sr. VP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $3.20 | $16,000.00 |
DisclosureSEC source: 0001209191-18-008165 · doc4.xml · nonDerivative · entry 1 Conner Edward R. · CIK 0001691265 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date. Read SEC document |
| February 01, 2018 Filed Feb 6, 2018 01:05 UTC |
Mento Steven JDirector
|
Exercise / conversionStockOption (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $10.17 | $0.00 |
DisclosureSEC source: 0001209191-18-007711 · doc4.xml · derivative · entry 6 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| February 01, 2018 Filed Feb 6, 2018 01:05 UTC |
Mento Steven JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001209191-18-007711 · doc4.xml · derivative · entry 5 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2021-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| February 01, 2018 Filed Feb 6, 2018 01:05 UTC |
Mento Steven JDirector
|
SaleCommon Stock | 11,520 | $20.59 | $237,158.78 |
DisclosureSEC source: 0001209191-18-007711 · doc4.xml · nonDerivative · entry 3 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,480 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2017. F2 · price: The price reported is a weighted average price. The shares were sold at prices ranging from $20.25 to $20.90 The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 01, 2018 Filed Feb 6, 2018 01:05 UTC |
Mento Steven JDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.17 | $101,700.00 |
DisclosureSEC source: 0001209191-18-007711 · doc4.xml · nonDerivative · entry 2 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 6, 2018 01:05 UTC |
Mento Steven JDirector
|
Exercise / conversionCommon Stock | 5,000 | $6.41 | $32,050.00 |
DisclosureSEC source: 0001209191-18-007711 · doc4.xml · nonDerivative · entry 1 Mento Steven J · CIK 0001324466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 6, 2018 01:04 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-18-007710 · doc4.xml · derivative · entry 3 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 15,000 shares Expires 2027-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vested and became exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured from the January 26, 2017 grant date, and the balance of the shares will vest and become exercisable in 36 successive equal monthly installments upon his completion of each additional month of service thereafter. Read SEC document |
| February 01, 2018 Filed Feb 6, 2018 01:04 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
SaleCommon Stock | 15,000 | $20.59 | $308,854.50 |
DisclosureSEC source: 0001209191-18-007710 · doc4.xml · nonDerivative · entry 2 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,625 F1 · kind: All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017. F2 · price: The price reported is a weighted average price. The shares were sold at prices ranging from $20.25 to $20.95 The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes (a) 8,375 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date; and (b) 6,250 shares subject to restricted stock units granted on December 8, 2015 that will vest on December 8, 2018, subject to the Reporting Person's continued service with the Issuer through such date. Read SEC document |
| February 01, 2018 Filed Feb 6, 2018 01:04 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 15,000 | $3.50 | $52,500.00 |
DisclosureSEC source: 0001209191-18-007710 · doc4.xml · nonDerivative · entry 1 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2018 Filed Feb 1, 2018 01:12 UTC |
Macrae SandyDirector · President, CEO and Director
|
GrantStock Option (Right to Buy) · Derivative | 189,000 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001209191-18-006340 · doc4.xml · derivative · entry 2 Macrae Sandy · CIK 0001675687 · Director · President, CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,000 Underlying: Common Stock · 189,000 shares Expires 2028-01-23 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares vest and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the January 24, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| January 24, 2018 Filed Feb 1, 2018 01:12 UTC |
Macrae SandyDirector · President, CEO and Director
|
GrantCommon Stock | 31,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006340 · doc4.xml · nonDerivative · entry 1 Macrae Sandy · CIK 0001675687 · Director · President, CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,500 F1 · balance_after: Represents 31,500 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date. Read SEC document |
| January 24, 2018 Filed Feb 1, 2018 01:11 UTC |
Yi KathySVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 43,500 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001209191-18-006339 · doc4.xml · derivative · entry 2 Yi Kathy · CIK 0001697802 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,500 Underlying: Common Stock · 43,500 shares Expires 2028-01-23 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares vest and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the January 24, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| January 24, 2018 Filed Feb 1, 2018 01:11 UTC |
Yi KathySVP & Chief Financial Officer
|
GrantCommon Stock | 7,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006339 · doc4.xml · nonDerivative · entry 1 Yi Kathy · CIK 0001697802 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250 F1 · balance_after: Represents 7,250 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date. Read SEC document |
| January 24, 2018 Filed Feb 1, 2018 01:10 UTC |
Conner Edward R.Sr. VP & Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 36,750 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001209191-18-006335 · doc4.xml · derivative · entry 2 Conner Edward R. · CIK 0001691265 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,750 Underlying: Common Stock · 36,750 shares Expires 2028-01-23 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares vest and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the January 24, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
| January 24, 2018 Filed Feb 1, 2018 01:10 UTC |
Conner Edward R.Sr. VP & Chief Medical Officer
|
GrantCommon Stock | 6,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006335 · doc4.xml · nonDerivative · entry 1 Conner Edward R. · CIK 0001691265 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,125 F1 · balance_after: Includes 6,125 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date. Read SEC document |
| January 24, 2018 Filed Feb 1, 2018 01:10 UTC |
Herberts Curt A. IIISr.VP & Chief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,250 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001209191-18-006336 · doc4.xml · derivative · entry 2 Herberts Curt A. III · CIK 0001691262 · Sr.VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,250 Underlying: Common Stock · 50,250 shares Expires 2028-01-23 F2 · derivative.exercise_date: One-quarter (1/4) of the option shares vest and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the January 24, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.